Recent advances in diagnosis and treatment of chronic myeloproliferative neoplasms

por Guglielmelli, Paola, Vannucchi, Alessandro M
Publicado 2010

Myeloid sarcoma: more and less than a distinct entity

por Loscocco, Giuseppe G., Vannucchi, Alessandro M.
Publicado 2023

Chronic Myeloproliferative Neoplasms: a Collaborative Approach

por Pieri, Lisa, Guglielmelli, Paola, Vannucchi, Alessandro M.
Publicado 2010

Polycythemia vera treatment algorithm 2018

por Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2018

Essential thrombocythemia treatment algorithm 2018

por Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2018

Prefibrotic myelofibrosis: treatment algorithm 2018

por Finazzi, Guido, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2018

Polycythemia vera: historical oversights, diagnostic details, and therapeutic views

por Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2021

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data

por Loscocco, Giuseppe G, Guglielmelli, Paola, Vannucchi, Alessandro M
Publicado 2020

Myelofibrosis Treatment Algorithm 2018

por Tefferi, Ayalew, Guglielmelli, Paola, Pardanani, Animesh, Vannucchi, Alessandro M.
Publicado 2018

Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms

por Barbui, Tiziano, Finazzi, Guido, Vannucchi, Alessandro M., De Stefano, Valerio
Publicado 2018

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms

por Loscocco, Giuseppe G., Coltro, Giacomo, Guglielmelli, Paola, Vannucchi, Alessandro M.
Publicado 2021

Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives

por Vannucchi, Alessandro M, Guglielmelli, Paola, Rambaldi, Alessandro, Bogani, Costanza, Barbui, Tiziano
Publicado 2009

The new WHO classification for essential thrombocythemia calls for revision of available evidences

por Barbui, Tiziano, Thiele, Jürgen, Ferrari, Alberto, Vannucchi, Alessandro M., Tefferi, Ayalew
Publicado 2020

Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera

por Barbui, Tiziano, De Stefano, Valerio, Ghirardi, Arianna, Masciulli, Arianna, Finazzi, Guido, Vannucchi, Alessandro M.
Publicado 2018

mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms

por Bogani, Costanza, Bartalucci, Niccolò, Martinelli, Serena, Tozzi, Lorenzo, Guglielmelli, Paola, Bosi, Alberto, Vannucchi, Alessandro M.
Publicado 2013

Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells

por Guglielmelli, Paola, Bisognin, Andrea, Saccoman, Claudia, Mannarelli, Carmela, Coppe, Alessandro, Vannucchi, Alessandro M., Bortoluzzi, Stefania
Publicado 2015

Validation of the Mayo alliance prognostic system for mastocytosis

por Mannelli, Francesco, Gesullo, Francesca, Rotunno, Giada, Pacilli, Annalisa, Pieri, Lisa, Guglielmelli, Paola, Vannucchi, Alessandro M.
Publicado 2019

Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms

por Bartalucci, Niccolò, Tozzi, Lorenzo, Bogani, Costanza, Martinelli, Serena, Rotunno, Giada, Villeval, Jean-Luc, Vannucchi, Alessandro M
Publicado 2013

Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis

por Loscocco, Giuseppe G., Santi, Raffaella, Carrai, Valentina, Coltro, Giacomo, Mannelli, Francesco, Guglielmelli, Paola, Vannucchi, Alessandro M.
Publicado 2022

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms

por Gianelli, Umberto, Thiele, Jürgen, Orazi, Attilio, Gangat, Naseema, Vannucchi, Alessandro M., Tefferi, Ayalew, Kvasnicka, Hans Michael
Publicado 2022